PRA acknowledges and thanks the members of the Rare Disease Advisory
Committee (RDAC) who provided their valuable contributions to the
development of these guidelines.
Easing the Rare Patient's Burden in Clinical Trials
The Center for Rare Diseases
We never forget that rare diseases alter entire lives—and we’re committed to changing that. Every day can be delayed, postponed, or canceled when…
RARE DISEASES NEWSLETTER Volume 8, January 2018
This quarterly publication will keep you up to date on PRA’s Rare Disease Team focus, achievements, and new initiatives.